BBH
VanEck Biotech ETF
BBH
VanEck Biotech ETF
BBH
VanEck Biotech ETF
BBH
VanEck Biotech ETF
-
NAV$159.02
as of December 26, 2024 -
YTD RETURNS--
as of December 26, 2024 -
Total Net Assets$401.75M
as of December 26, 2024 -
Total Expense Ratio0.35%
-
Inception Date12/20/2011
Fund Description
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
Overview
Fund Highlights
- Highly Liquid Companies
Index seeks to track the most liquid companies in the industry based on market cap and trading volume
- Industry Leaders
Index methodology favors the largest companies in the industry
- Global Scope
Portfolio may include both domestic and U.S. listed foreign companies allowing for enhanced industry representation